Atavistik Bio Raises Additional $40 Million To Advance Precision Allosteric Small Molecule Therapeutics
Amount Raised
$40 Million
Round Type
Funding Round
CambridgeBiotechnologySoftwareHealth CareScience And EngineeringDescription
Atavistik Bio, a biotechnology company discovering the next generation of precision allosteric therapeutics inspired by the body’s natural regulators, today announced that it has raised an additional $40 million to advance its lead precision allosteric small molecule therapeutic in oncology into the clinic and to advance its earlier stage pipeline. The financing included existing investors, including The Column Group, Lux Capital, and Nextech Invest, Ltd. Atavistik Bio has raised $100 million in aggregate since its launch in August 2021.
Quick answer
Atavistik Bio raised $40 Million in a Funding Round round, dated December 19, 2023. Atavistik Bio is based in Cambridge, Massachusetts, United States.
- How much did Atavistik Bio raise?
- Atavistik Bio raised $40 Million in a Funding Round round on December 19, 2023.
- What does Atavistik Bio do?
- Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology.
- Where is Atavistik Bio based and how big is it?
- Atavistik Bio is based in Cambridge, Massachusetts, United States. Fundz records about 38 employees.
- Who are the decision-makers at Atavistik Bio?
- Fundz holds 1 contact at Atavistik Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Atavistik Bio that raised within 45 days of this round, from Fundz verified event records.
- RedHill Biopharma Ltd raised $10M on January 25, 2024.
- SeLux Diagnostics, Inc. raised $40M on February 1, 2024.
- Unlearn raised $50M on January 25, 2024.
- Athos Therapeutics, Inc. raised $20M on January 22, 2024.
- Streamex Corp. raised $1.5M (Seed) on January 12, 2024.
- Nabla raised $24M (Series B) on January 5, 2024.
Who to call at Atavistik Bio, and when
A new round usually means Atavistik Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Atavistik Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atavistik Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atavistik Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atavistik Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Atavistik Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.